Mounting evidence has shown the abnormal expression of circ-Foxo3 in numerous human cancers, including breast cancer (BC), lung cancer, glioma, ESCC, leukemia, gastric cancer (GC), bladder cancer, prostate cancer (PCa) and OC. Here, FOXO3 is linked to urinary bladder cancer.